Mariner’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $72.9M | Buy |
384,328
+12,405
| +3% | +$2.33M | 0.08% | 203 |
|
|
2026
Q1 | $73.3M | Buy |
371,923
+26,763
| +8% | +$5.16M | 0.09% | 188 |
|
|
2025
Q4 | $63.5M | Buy |
345,160
+8,900
| +3% | +$1.56M | 0.08% | 213 |
|
|
2025
Q3 | $51.6M | Buy |
336,260
+5,219
| +2% | +$790K | 0.07% | 241 |
|
|
2025
Q2 | $46.3M | Buy |
331,041
+103,247
| +45% | +$14.5M | 0.07% | 254 |
|
|
2025
Q1 | $33.5M | Buy |
227,794
+125,009
| +122% | +$18.1M | 0.06% | 278 |
|
|
2024
Q4 | $13.5M | Buy |
102,785
+12,999
| +14% | +$1.82M | 0.02% | 460 |
|
|
2024
Q3 | $14M | Buy |
89,786
+2,927
| +3% | +$472K | 0.02% | 438 |
|
|
2024
Q2 | $13.5M | Buy |
86,859
+29,237
| +51% | +$4.4M | 0.03% | 423 |
|
|
2024
Q1 | $7.81M | Sell |
57,622
-13,557
| -19% | -$1.8M | 0.02% | 579 |
|
|
2023
Q4 | $9.59M | Sell |
71,179
-1,436
| -2% | -$187K | 0.02% | 483 |
|
|
2023
Q3 | $9.83M | Sell |
72,615
-2,834
| -4% | -$387K | 0.03% | 439 |
|
|
2023
Q2 | $10.8M | Buy |
75,449
+1,993
| +3% | +$293K | 0.03% | 416 |
|
|
2023
Q1 | $10.2M | Buy |
73,456
+16,963
| +30% | +$2.28M | 0.03% | 431 |
|
|
2022
Q4 | $7.66M | Sell |
56,493
-2,809
| -5% | -$352K | 0.02% | 473 |
|
|
2022
Q3 | $6.5M | Buy |
59,302
+29,229
| +97% | +$3.71M | 0.03% | 439 |
|
|
2022
Q2 | $3.97M | Sell |
30,073
-1,243
| -4% | -$163K | 0.02% | 543 |
|
|
2022
Q1 | $4.16M | Buy |
31,316
+2,369
| +8% | +$284K | 0.02% | 538 |
|
|
2021
Q4 | $3.37M | Buy |
28,947
+5,768
| +25% | +$679K | 0.01% | 518 |
|
|
2021
Q3 | $2.78M | Buy |
23,179
+5,128
| +28% | +$597K | 0.01% | 464 |
|
|
2021
Q2 | $2.16M | Buy |
18,051
+981
| +6% | +$108K | 0.01% | 473 |
|
|
2021
Q1 | $1.7M | Buy |
17,070
+2,488
| +17% | +$250K | 0.01% | 489 |
|
|
2020
Q4 | $1.46M | Sell |
14,582
-3,706
| -20% | -$393K | 0.01% | 491 |
|
|
2020
Q3 | $2M | Sell |
18,288
-1,279
| -7% | -$142K | 0.02% | 373 |
|
|
2020
Q2 | $2.07M | Buy |
19,567
+5,152
| +36% | +$532K | 0.02% | 375 |
|
|
2020
Q1 | $1.29M | Buy |
14,415
+5,716
| +66% | +$538K | 0.02% | 432 |
|
|
2019
Q4 | $867K | Buy |
8,699
+177
| +2% | +$16.7K | 0.01% | 528 |
|
|
2019
Q3 | $760K | Sell |
8,522
-340
| -4% | -$29.5K | 0.01% | 521 |
|
|
2019
Q2 | $732K | Buy |
8,862
+1,456
| +20% | +$114K | 0.01% | 603 |
|
|
2019
Q1 | $599K | Buy |
+7,406
| New | +$584K | 0.01% | 606 |
|
|
2018
Q3 | – | Sell |
-3,548
| Closed | -$249K | – | 810 |
|
|
2018
Q2 | $249K | Buy |
+3,548
| New | +$255K | 0.01% | 683 |
|
Other funds holding AZN
EP
IA
Mariner's AZN Position: Q2 2026 in Review
Mariner increased its AstraZeneca (AZN) stake by 3.3% in Q2 2026, buying an estimated $2.33M and bringing the position to 384,328 shares worth $72.9M. The position accounts for 0.08% of the portfolio, ranked #203.
Mariner first reported a position in AZN in Q2 2018 and has held it in 31 quarters since. The position peaked at $73.3M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Mariner held 384,328 shares of AstraZeneca worth $72.9M as of Q2 2026.
- Mariner bought 12,405 AstraZeneca shares in Q2 2026, an estimated $2.33M.
- AstraZeneca made up 0.08% of Mariner's portfolio in Q2 2026, its #203 holding.
- Mariner first reported a position in AstraZeneca in Q2 2018 and has held it in 31 quarters since.
- Mariner's AstraZeneca position peaked at $73.3M in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.